Steve Middleton
Overview
Explore the profile of Steve Middleton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirza A, Aylin P, Middleton S, King E, Nouraei R, Repanos C
Head Neck
. 2018 Dec;
41(3):692-700.
PMID: 30593707
Background: Socioeconomic status plays an important role in the incidence and prognosis of many cancers. We examined the relationship between social deprivation and clinical outcomes in patients undergoing major surgery...
2.
Lingsma H, Bottle A, Middleton S, Kievit J, Steyerberg E, Marang-van de Mheen P
BMC Health Serv Res
. 2018 Feb;
18(1):116.
PMID: 29444713
Background: Hospital mortality, readmission and length of stay (LOS) are commonly used measures for quality of care. We aimed to disentangle the correlations between these interrelated measures and propose a...
3.
Leone J, Middleton S
J Athl Train
. 2016 Sep;
51(8):651-657.
PMID: 27626835
Objective: To discuss the case of a 49-year-old man who presented to the sports medicine staff with pelvic pain of 10 years' duration consistent with pudendal neuralgia. Background: Testicular pain...
4.
Andreeff M, Kelly K, Yee K, Assouline S, Strair R, Popplewell L, et al.
Clin Cancer Res
. 2015 Oct;
22(4):868-76.
PMID: 26459177
Purpose: RG7112 is a small-molecule MDM2 antagonist. MDM2 is a negative regulator of the tumor suppressor p53 and frequently overexpressed in leukemias. Thus, a phase I study of RG7112 in...